Key Challenges within CAR T-cell Clinical Trials

CAR T-cell therapies involve genetically modifying a patient’s T cells which requires careful oversight by regulatory agencies to maximize safety and efficacy. This in turn often leads to complex regulatory challenges. The panelists explain some of these challenges and what they do to face them.